학술논문

The proteolysis targeting chimera GMB-475 combined with dasatinib for the treatment of chronic myeloid leukemia with BCR::ABL1 mutants
Document Type
Journal
Source
FRONTIERS IN PHARMACOLOGY; OCT 3 2022, 13 p931772 17p.
Subject
Language
English
ISSN
16639812